Craniocerebral maduromycosis

J Neurosurg Pediatr. 2012 Jul;10(1):67-70. doi: 10.3171/2012.3.PEDS1252. Epub 2012 Jun 15.

Abstract

Craniocerebral maduromycetoma is extremely rare; only 2 cases have been reported so far. The authors report a case of maduromycetoma in a 17-year-old girl from a rural background in the state of Rajasthan, India, with involvement of the right parietal cortex, overlying bone, and subcutaneous tissue. The mass was totally excised, along with the involved dura mater, bone, and scalp. She was given antifungal drugs in the postoperative period. The patient responded very well to the treatment, and there were no signs of recurrence at the 6-month follow-up visit. The clinical features, imaging and histopathological investigations, and management of this rare entity are discussed, and the available literature is reviewed.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antifungal Agents / therapeutic use*
  • Bone Diseases* / diagnosis
  • Bone Diseases* / therapy
  • Brain Diseases* / diagnosis
  • Brain Diseases* / therapy
  • Female
  • Humans
  • India
  • Madurella / isolation & purification*
  • Magnetic Resonance Imaging
  • Mycetoma* / diagnosis
  • Mycetoma* / therapy
  • Naphthalenes / administration & dosage
  • Parietal Lobe / microbiology*
  • Pyrimidines / administration & dosage
  • Scalp / microbiology*
  • Seizures / microbiology*
  • Terbinafine
  • Tomography, X-Ray Computed
  • Triazoles / administration & dosage
  • Voriconazole

Substances

  • Antifungal Agents
  • Naphthalenes
  • Pyrimidines
  • Triazoles
  • Terbinafine
  • Voriconazole